Prognostic value of melatonin-related signature genes in lung adenocarcinoma
PLOS One · 2026
DOI: 10.1371/journal.pone.0357584 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Hongxia Guo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic-cancer, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical …. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Melatonin, Lung Neoplasms. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shanxi Province.
Abstract (Originalsprache)
Purpose
Lung adenocarcinoma (LUAD), the most prevalent lung cancer subtype, has witnessed a dramatic upsurge in frequency over the past 20 years. This study intended to construct a predictive risk model and analyze melatonin (ME)-associated genes in LUAD.
Methods
Differentially expressed genes (DEGs) were found by using DESeq2 to analyze the TCGA-LUAD dataset. ME-DEGs were discovered near the junction, and ME critical module genes were identified by WGCNA. To build a risk model, model genes from ME-DEGs were chosen using univariate and multivariate Cox analysis. The samples were categorized as either low-risk or high-risk. The model was verified using the GSE31210 dataset. Gene expression was confirmed by RT-qPCR, immunological studies were performed, and a nomogram was developed.
Results
The 98 ME-DEGs were obtained by combining 1,052 ME key module genes with 5,449 LUAD-DEGs. Eight model genes were selected using univariate and multivariate cox regression analyses. The risk model, which was constructed using model genes, showed good predictive performance in both the TCGA-LUAD and GSE31210 datasets. Additionally, the nomogram’s superior predictive accuracy for LUAD was confirmed by calibration and receiver operating characteristic (ROC) curves. Additionally, the results of immune analysis showed that ALG3 and FRY had significant relationships with immune cells and immune checkpoints, and that E2F1 had a significant negative association with FRY.
Conclusion
We developed and validated a novel ME-related prognostic model for LUAD. This algorithm may be able to predict patient outcomes and provide recommendations for tailored immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Thoracic-cancer, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China.
- Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Traditional Chinese Medicine, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Tai…
- Department of Radiotherapy, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi, Ch…
- Department of Radiotherapy, Shanxi Province Cancer Hospital/ Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi, C…
ORCID-Profile: Tong Cui
Förderung
- Natural Science Foundation of Shanxi Province
Zitieren
APA
Guo, H., Liu, L., Lu, Y., Ma, Y., Ren, X., & Cui, T. (2026). Prognostic value of melatonin-related signature genes in lung adenocarcinoma. PLOS One. https://doi.org/10.1371/journal.pone.0357584
Vancouver
Guo H, Liu L, Lu Y, Ma Y, Ren X, Cui T. Prognostic value of melatonin-related signature genes in lung adenocarcinoma. PLOS One. 2026. doi:10.1371/journal.pone.0357584
BibTeX
@article{Guo2026,
author = {Guo, Hongxia and Liu, Lixia and Lu, Ying and Ma, Yuhui and Ren, Xiaolu and Cui, Tong},
title = {Prognostic value of melatonin-related signature genes in lung adenocarcinoma},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0357584}
}
EUVIMED